Live news related to GENOWAY stock (FR0004053510): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The latest financial news on GENOWAY mainly cover earnings publications, M&A activity et the dividend and payout policy. The stock trades at €2,48 on Euronext Paris, up 0,40% at the last update. This page lists the articles published on GENOWAY stock to track the share price, company announcements and any item likely to influence market perception.
GenOway reported total revenues of €10.9M in the first half of 2026, a 10% increase from the first half of 2025. Behind this moderate rise, a strategi…
genOway announces the opening of its first two distribution franchises in Canada and Australia, marking a key milestone in its strategic plan ROUTE50+…
GenOway has emerged from a year of forced transformation. While its revenue declined by 5% in 2025 in a cautious economic environment, the Lyon-based …
GenOway announces the establishment of GenOway Japan, a wholly-owned subsidiary aimed at promoting and developing the sale of preclinical models in im…
The company specializing in predictive preclinical solutions announced its annual results for 2025 on Monday, marked by a stabilization in the second …
